KinoPharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series E

  • Investors
  • 19

KinoPharma General Information

Description

Developer of molecule drugs designed to provide antiviral medication to women for papillomavirus (HPV) infection. The company's research responds to the discovery and clinical development of next-generation antifungal remedies using an approach different from conventional antibacterial medicine strategies, enabling women to treat cervical cancer before it develops.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 705 Nihonbashi Life Science Building 2
  • 3-11-5 Nihonbashi Honcho, Chuo-ku
  • Tokyo, 103-0023
  • Japan
+81
Primary Industry
Drug Discovery
Corporate Office
  • 705 Nihonbashi Life Science Building 2
  • 3-11-5 Nihonbashi Honcho, Chuo-ku
  • Tokyo, 103-0023
  • Japan
+81

KinoPharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KinoPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series E) 28-Feb-2025 Completed Clinical Trials - Phase 2
11. Later Stage VC 31-Jul-2023 Completed Clinical Trials - Phase 2
10. Secondary Transaction - Private 01-Mar-2023 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series D) 10-Dec-2021 Completed Clinical Trials - Phase 2
8. Later Stage VC 31-Mar-2020 Completed Startup
7. Later Stage VC Completed Startup
6. Later Stage VC Completed Startup
5. Later Stage VC Completed Startup
4. Later Stage VC 14-Sep-2018 $9M $9.6M Completed Startup
3. Later Stage VC 27-Dec-2016 $605K $605K Completed Startup
To view KinoPharma’s complete valuation and funding history, request access »

KinoPharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class G
Class F
Class E
Class D
Class C
Class B 300 $2125.61 $2125.61 1x $2125.61 4.38%
Class A 700 $708.54 $708.54 1x $708.54 10.22%
To view KinoPharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

KinoPharma Patents

KinoPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4520330-A1 Aniline-derivative-containing external agent for skin Pending 02-May-2022
EP-4520330-A4 Aniline-derivative-containing external agent for skin Pending 02-May-2022
WO-2023214568-A1 Aniline-derivative-containing external agent for skin Inactive 02-May-2022
AU-2023265202-A1 Aniline-derivative-containing external preparation for skin Pending 02-May-2022
US-20250339420-A1 Aniline-derivative-containing external preparation for skin Pending 02-May-2022 A61K31/4545
To view KinoPharma’s complete patent history, request access »

KinoPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KinoPharma Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
AirTrip Corporation Minority
Awagin Capital PE/Buyout Minority
Iwagin Jigyo Souzou Capital Venture Capital Minority
Kyoshin Social Capital Corporate Venture Capital Minority
NCB Capital (Fukuoka) Corporate Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

KinoPharma FAQs

  • When was KinoPharma founded?

    KinoPharma was founded in 2005.

  • Where is KinoPharma headquartered?

    KinoPharma is headquartered in Tokyo, Japan.

  • What is the size of KinoPharma?

    KinoPharma has 10 total employees.

  • What industry is KinoPharma in?

    KinoPharma’s primary industry is Drug Discovery.

  • Is KinoPharma a private or public company?

    KinoPharma is a Private company.

  • What is KinoPharma’s current revenue?

    The current revenue for KinoPharma is .

  • How much funding has KinoPharma raised over time?

    KinoPharma has raised $29.9M.

  • Who are KinoPharma’s investors?

    AirTrip, Awagin Capital, Iwagin Jigyo Souzou Capital, Kyoshin Social Capital, and NCB Capital (Fukuoka) are 5 of 19 investors who have invested in KinoPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process